A study of onabotulinum toxin A for treatment of chronic posttraumatic headache in individuals with mild traumatic brain injury.

Trial Profile

A study of onabotulinum toxin A for treatment of chronic posttraumatic headache in individuals with mild traumatic brain injury.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Jul 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Headache
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jul 2017 New trial record
    • 11 Jun 2017 Results (n=13) presented at the 59th Annual Scientific Meeting of the American Headache Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top